Back to Agendas
Optimizing Investigative Site/Country Selection Using Online Feasibility Tools, Big Data, and Disruptive Technologies
Session Chair(s)
Gustavo Kesselring, MD
Senior Visiting Lecturer
KING´S COLLEGE LONDON, Brazil
This symposium will address how management of big data analytics, visualization systems and social networks can accelerate and reduce cost of trial planning process through an innovative online feasibility assessment that interacts with research sites. Methods for assessing dynamic global regulatory approval timelines and their impact on the development of optimal country strategies for clinical trials will be discussed. We will conclude with an investigation of how disruptive technologies are changing processes, the performance metrics that can be collected, as well as our expectations of what constitutes acceptable performance.
Learning Objective : Discuss how to take advantage of reliable, up-to-date, and easily accessible information in developing global country and site selection strategies; Evaluate a potential new method to more effectively assess prospective country-level timelines to inform the development of the country strategy for a clinical trial; Apply lessons learned regarding the appropriate use of performance metrics.
Speaker(s)
Connecting the Right Sites to Promising Trials: The Role of Online Feasibility Assessment
Fabio Thiers, MD, PhD, MSc
IMS Health, United States
Product Manager, CTOS
The Metrics Evolution: Using Better Metrics to Inform Decision-Making and Streamline Clinical Trial Operations
Linda B Sullivan, MBA
Tufts Center For the Study of Drug Development, United States
Senior Fellow
Using Big Data to Supplement Traditional Performance and Capability Metrics and Optimize Investigative Site Identification and Selection
Shawn Tedman, MBA
ixlayer, United States
VP, Biopharma Innovation
Have an account?